Aug 20, 09:07
AnnouncementsSuven Life Sciences to consider dividend on May 22, 2014
Suven Life Sci
52% of moneycontrol users recommend buying Suven Life Sci.
What's your call on Suven Life Sci today?
Read 38 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2888.00||2.25||2939.80||2140.35||49,192.76|
|Mar' 14||Dec' 13||Jun' 13||Mar' 13|
|Scheme||No. of Shares|
|IDFC Equity Opportunity - Series 1 - Direct Plan (Dividend Payout)||478,845|
|IDFC Equity Opportunity - Series 1 - Regular (Dividend Payout)||30,523|
Kwality Recommended on Jun 25th 2014
Recommended price 45.00 | Peak from reco 58.00 28.89%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Suven Life Sci is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,518.19 crore.The company has reported a standalone sales of Rs 130.80 crore and a Net Profit of Rs 32.41 crore for the quarter ended Mar 2014.
The company management includes Venkateswarlu Jasti - Chairman & CEO, Sudha Rani Jasti - Whole Time Director, M R Naidu - Director, K V Raghavan - Director, D G Prasad - Director, Syed E Hasnain - Director, M Gopala Krishna - Director.
It is listed on the BSE with a BSE Code of 530239 and the NSE with an NSE Code of SUVEN.
Its Registered office is at 8-2-334, SDE Serene Chambers, 6th Floor, Road No. 5,,Avenue 7, Hyderabad,Andhra Pradesh - 500034.
Their Registrars are Karvy Computershare Private Ltd.